These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2280278)

  • 21. Human growth hormone and Creutzfeldt-Jakob disease.
    Bol Asoc Med P R; 1988 Jul; 80(7):253-7. PubMed ID: 3048299
    [No Abstract]   [Full Text] [Related]  

  • 22. Creutzfeldt-Jakob disease, leukemia and growth hormone therapy.
    Can Dis Wkly Rep; 1989 Oct; 15(42):212. PubMed ID: 2691104
    [No Abstract]   [Full Text] [Related]  

  • 23. Problems with growth hormone.
    Med Lett Drugs Ther; 1985 Jul; 27(691):57-8. PubMed ID: 3892258
    [No Abstract]   [Full Text] [Related]  

  • 24. [Growth hormone and Creutzfeldt-Jakob disease].
    Goujard J
    Rev Epidemiol Sante Publique; 1993; 41(6):513-4. PubMed ID: 8296041
    [No Abstract]   [Full Text] [Related]  

  • 25. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
    Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
    Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creutzfeldt-Jakob disease after administration of human growth hormone.
    Powell-Jackson J; Weller RO; Kennedy P; Preece MA; Whitcombe EM; Newsom-Davis J
    Lancet; 1985 Aug; 2(8449):244-6. PubMed ID: 2862420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prions, Jakob-Creutzfeldt disease and human growth hormone].
    González PM
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):207-9. PubMed ID: 3296112
    [No Abstract]   [Full Text] [Related]  

  • 28. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1978-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1152-4. PubMed ID: 18946463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era.
    Brown P; Brandel JP; Preece M; Sato T
    Neurology; 2006 Aug; 67(3):389-93. PubMed ID: 16855204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The missing link.
    Eaton L
    Nurs Times; 1993 Sep 22-28; 89(38):19. PubMed ID: 8415073
    [No Abstract]   [Full Text] [Related]  

  • 31. Surveillance for Creutzfeldt-Jakob disease--United States.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Aug; 45(31):665-8. PubMed ID: 8769655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Creutzfeldt-Jakob verdict may prompt new claims.
    Carr K
    Nature; 1993 Nov; 366(6451):98. PubMed ID: 8232564
    [No Abstract]   [Full Text] [Related]  

  • 33. [Growth hormone and Creutzfeldt-Jakob disease].
    Christiansen JS; Kastrup KW
    Ugeskr Laeger; 1997 Jun; 159(26):4141-2. PubMed ID: 9229877
    [No Abstract]   [Full Text] [Related]  

  • 34. [Is there a causative relation between infectious degenerative encephalopathy and the use of growth hormone?].
    Romer TE
    Pediatr Pol; 1986 Nov; 61(11):740-4. PubMed ID: 3295737
    [No Abstract]   [Full Text] [Related]  

  • 35. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy.
    Fisman M
    N Engl J Med; 1986 Apr; 314(15):987-8. PubMed ID: 3515181
    [No Abstract]   [Full Text] [Related]  

  • 36. Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(24):359-60, 365-6. PubMed ID: 3923319
    [No Abstract]   [Full Text] [Related]  

  • 37. A statistical model to identify the contaminated lots implicated in iatrogenic transmission of Creutzfeldt-Jakob disease among French human growth hormone recipients.
    Huillard d'Aignaux J; Alpérovitch A; Maccario J
    Am J Epidemiol; 1998 Mar; 147(6):597-604. PubMed ID: 9521187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study on the innocuity of the hypophyseal human growth hormone.
    Simionescu L; Câmpean G; Dimitriu V; Zamfir-Grigorescu D; Neacşu E; Dumitriu E; Ionescu T; Drăgănescu N; Cernescu C
    Endocrinologie; 1989; 27(3):133-47. PubMed ID: 2510246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contamination of human growth hormone with Creutzfeldt-Jakob disease agent.
    Taylor DM
    Biomed Pharmacother; 1987; 41(5):255. PubMed ID: 3311193
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood.
    Holmes SJ; Ironside JW; Shalet SM
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):333-5. PubMed ID: 8609514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.